APA (7th ed.) Citation

Nowak, R. J., Brew, S. G., Frey, M., McCarthy, D. P., & Elhofy, A. Antigen-specific immune therapy (CNP-106) for treatment of generalised myasthenia gravis: Rationale and design of first-in-human randomised controlled trial. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Nowak, Richard J., Samantha G. Brew, Molly Frey, Derrick P. McCarthy, and Adam Elhofy. Antigen-specific Immune Therapy (CNP-106) for Treatment of Generalised Myasthenia Gravis: Rationale and Design of First-in-human Randomised Controlled Trial. BMJ Publishing Group.

MLA (9th ed.) Citation

Nowak, Richard J., et al. Antigen-specific Immune Therapy (CNP-106) for Treatment of Generalised Myasthenia Gravis: Rationale and Design of First-in-human Randomised Controlled Trial. BMJ Publishing Group.